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Abstract
Background: Despite the increasing interest towards the biological role of L-ergothioneine, little is known about the serum
concentrations of this unusual aminothiol in older adults. We addressed this issue in a representative sample of community-
dwelling middle-aged and older adults.
Methods: Body mass index, estimated glomerular filtration rate, serum concentrations of L-ergothioneine, taurine,
homocysteine, cysteine, glutathione, cysteinylglycine, and glutamylcysteine were evaluated in 439 subjects (age 55–85
years) randomly selected from the Hunter Community Study.
Results: Median L-ergothioneine concentration in the entire cohort was 1.01 IQR 0.78–1.33 mmol/L. Concentrations were
not affected by gender (P = 0.41) or by presence of chronic medical conditions (P = 0.15). By considering only healthy
subjects, we defined a reference interval for L-ergothioneine serum concentrations from 0.36 (90% CI 0.31–0.44) to 3.08
(90% CI 2.45–3.76) mmol/L. Using stepwise multiple linear regression analysis L-ergothioneine was negatively correlated with
age (rpartial =20.15; P = 0.0018) and with glutamylcysteine concentrations (rpartial =20.13; P = 0.0063).
Conclusions: A thorough analysis of serum L-ergothioneine concentrations was performed in a large group of community-
dwelling middle-aged and older adults. Reference intervals were established. Age and glutamylcysteine were independently
negatively associated with L-ergothioneine serum concentration.
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Introduction
It is generally accepted that damage caused by free radicals is a
hallmark of ageing with potential clinical consequences [1]. In
humans, a complex of enzymatic and non-enzymatic antioxidants
reacts to neutralize these damaging molecules and exogenous
substances may play a crucial role in this context [1]. Although its
specific physiological role and the consequences of its deficiency
are unclear, among exogenous compounds with possible antiox-
idant activity, the interest toward ergothioneine (ERT; 2-
mercaptohistidine trimethylbetaine) has been increasing in the
last years. ERT is an unusual hydrophilic low-molecular-weight
thiol [2], exclusively synthesized in few organisms such as non-
yeast-like fungi including edible mushrooms [3], mycobacteria [4]
and cyanobacteria [5].
Early studies showed that humans and other vertebrates are
unable to biosynthesize ERT, and that in mammals it is acquired
solely by dietary means [2]. A specific organic cation transporter
protein (ETT), codified by the SLC22A4 gene [6], is responsible
for its accumulation in the body at millimolar levels [7,8]. ETT is
strongly expressed in fetal liver, small intestine, trachea, kidney,
cerebellum, lung, and cells of the myeloic lineage such as
erythrocyte progenitor cells in bone marrow and monocytes [8].
Cells lacking ETT do not accumulate ERT and its uptake does not
appear to be related to dietary sources but, rather, to the
expression of ETT mRNA [2]. The existence of a specific
transporter suggests a biological role for ERT. Moreover, case-
control studies have showed associations between polymorphisms
in the SLC22A4 gene and susceptibility to some chronic
inflammatory diseases such as Crohn’s disease [9], ulcerative
colitis [10], rheumatoid arthritis [11], and Type I diabetes [12].
ERT concentrates especially in mitochondria and in cells and
tissues normally exposed to oxidative stress and those involved in
an inflammatory response [3]. These observations suggest that
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ERT might have antioxidant and scavenging activities, similarly to
the main water-soluble antioxidant thiol glutathione [13]. ERT
chemistry, however, differs from conventional sulfur-containing
antioxidants. ERT, in fact, exists as a tautomer between its thiol
and thione forms, with the latter predominating under physiolog-
ical conditions [7]. Consequently, ERT shows a peculiar stability
and reactivity compared to other naturally occurring thiols, since it
does not autooxidize [6], does not form disulphides and mixed
disulphides [14], requires a more severe oxidative stress to oxidize
and does not promote the classical Fenton reaction [6].
The knowledge regarding tissue ERT concentration distribution
at population level is limited to one study in 400 healthy male
individuals [15]. Reported erythrocyte ERT concentration,
averages and ranges, differed across age groups, i.e. 65.42–
109.03 mM (1–10 years), 161.36 mM (11–18 years), 100.30–
130.83 mM (19–50 years) and 122.11 mM ($51 years) [15]. No
data, instead, are available on ERT concentrations in human
serum. This is possibly due to the lack of reliable analytical
methods with adequate sensitivity as serum ERT concentration is
much lower vs. erythrocytes. To this regard, we have recently
developed the first capillary electrophoresis-laser-induced fluores-
cence (CE-LIF) method for the rapid evaluation of plasma or
serum ERT concentrations [16]. The assay method was able to
quantitatively detect and measure ERT concentrations as low as
0.27 mmol/L, with a limit of detection of 90 nmol/L.
Given the availability of this new sensitive assay method, we
studied the distribution of serum ERT concentrations in an
established epidemiological cohort of human ageing, the Hunter




Participants were a representative sample of the Hunter
Community Study (HCS), a population-based cohort study to
assess the impact of clinical, genetic, biochemical, socioeconomic,
and behavioural factors on human ageing [17]. The cohort
consisted of community-dwelling men and women aged 55 to 85
years residing in Newcastle (New South Wales, Australia),
randomly selected from the electoral roll and contacted between
December 2004 and December 2007. Of the 9,784 individuals
who received the invitation letter, a total of 3,253 actually took
part (response rate 44.5% after removing incorrect addresses and
non-contacts) and completed a series of self-reported question-
naires, attended a clinic visit, consented to linkage of health
records and to undergo to a series of clinical and biochemical
measures. The sample for this investigation (n = 500) was derived
from the initial cohort by simple random sampling. Of the 500
subjects randomly selected, complete exposure and outcome data
at baseline were available for 439 subjects, 227 males and 212
females. The comparison of this sample with the entire cohort
showed no significant difference for a range of clinical, biochem-
ical, socioeconomic, and behavioural factors (data not shown),
ensuring that the sampling was representative of the original
cohort. Approval to conduct the research was granted by the
University of Newcastle Human Research Ethics Committees, it
was performed in accordance with the guidelines of the
Declaration of Helsinki and, after being informed, all participants
gave written informed consent.
Blood Sample Collection and ERT Analysis
Blood was collected into tubes without anticoagulant and
centrifuged at 4uC and 3,0006g for 10 min to separate serum,
which was stored for three years at 280uC before analysis. There
was no previous freeze-thaw cycles prior to analysis. Serum ERT
concentration was measured by capillary electrophoresis-laser-
induced fluorescence method as recently described by Sotgia et al.
[16]. Briefly, to precipitate the proteins, a 100 mL-volume of
acetonitrile was added to 100 mL of sample and mixed thoroughly
by vigorous vortex-mixing. After centrifugation at 17,0006g for
10 min at room temperature, 50 mL of the derivatization reagent
were added to 150 mL of supernatant and, after vigorous vortex-
mixing, reaction mixture was left in a light-protected area for
30 min at room temperature. Finally, samples were diluted with
water fifty times and analysed by CE-LIF. The limits of detection
and of quantification were 0.09 and 0.27 mmol/l, respectively.
The variations for intra- and inter-assay precision were around 6
RSD%, and the mean recovery accuracy close to 100% (96.11%).
Figure 1. Distribution of ERT concentrations in the population (A) before and (B) after log10 transformation. Lowest and highest
values were, respectively, 0.26 and 5.06 mM. Geometric mean after back transformation of log-transformed data was 1.05 mM and 95% CI for the
mean was 1.01 to 1.10 mM. Median was 1.01 mM and 95% CI for the median 0.96 to 1.06 mM.
doi:10.1371/journal.pone.0084918.g001
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Demographic, Clinical and Biochemical Variables
This study examined the association between serum ERT with
age, gender, body mass index (BMI), estimated glomerular
filtration rate (eGFR), and the thiols homocysteine (Hcy), cysteine
(Cys), glutathione (GSH), cysteinylglycine (CysGly), glutamylcys-
teine (GluCys), and taurine (Tau). Body mass index was calculated
using height and weight measurements obtained at baseline and
eGFR was calculated using the Modification of Diet in Renal
Disease formula [18]. Serum concentrations of the thiols
homocysteine (Hcy), cysteine (Cys), glutathione (GSH), cysteinyl-
glycine (CysGly), glutamylcysteine (GluCys), and taurine (Tau)
were measured previously by CE-LIF methods, as described by
Zinellu et al. [19,20]. eGFR has been shown to be an independent
determinant of plasma concentrations of Hcy, Cys and CysGly.
Therefore, it was used to assess potential associations between
ERT concentrations and kidney function [21,22]. In view of the
dietary origin of ERT, BMI was used as a surrogate marker of
nutritional status. BMI and other measures of adiposity, in fact,
have been associated to concentrations of biochemical markers of
nutritional status. [23] A self-administered questionnaire was used
to collect information of existing chronic medical conditions such
as cardiovascular disease, type 2 diabetes, arthritis and depression.
Study participants were asked if they had ever received a physician
diagnosis of a range of medical conditions and the age that they
received the diagnosis.
Statistical
Statistical analyses were performed using MedCalc for Win-
dows, version 12.5 64 bit (MedCalc Software, Ostend, Belgium)
and SPSS for Windows, version 14.0 32 bit (IBM Corporation;
Armonk, NY, USA). Data were tested for normality of distribution
using the Kolmogorov-Smirnov test. Data were presented as either
mean6SD or median and interquartile range (IQR) as appropri-
ate. Non-normally distributed variables were log10-transformed
prior to being used with parametric tests, and the normal
distribution of the residuals was checked to assess the goodness
of fit of the transformations. Differences between groups were
compared by non-parametric Mann-Whitney U Test or by
independent t-test as appropriate. Spearman rank correlation
coefficients were used to characterise associations between serum
ERT concentration and continuous clinical, biochemical and
demographic variables. Partial correlation and stepwise multiple
linear regression analysis was used to assess the contribution of
different variables to serum ERT concentration. Multicollinearity
Table 1. Clinical, demographic, and biochemical characteristics of the 439 older subjects.
All (n = 439) Healthy (n =80) Unehalthy (n=359)
Females % 48.3 42.5 49.6
Age years, median (IQR) 64 (60–70) 62 (59–66) 65 (60–71)
ERT mM, median (IQR) 1.01 (0.78–1.35) 0.99 (0.84–1.52) 1.01 (0.77–1.33)
BMI Kg/m2, median (IQR) 28.0 (25.8–31.3) 26.7 (25.4–29.6) 28.4 (25.9–31.8)
eGFRa ml/min, mean6SD 78616 80614 78617
Tau mM, median (IQR) 62.40 (52.25–83.67) 60.13 (52.47–79.15) 63.57 (52.20–84.20)
CysGly mM, median (IQR) 29.01 (25.50–33.18) 28.73 (25.81–32.08) 29.12 (25.43–33.48)
Hcy mM, median (IQR) 9.14 (7.94–11.06) 8.65 (7.58–10.10) 9.28 (8.02–11.26)
Cys mM, mean 6SD 188.99637.10 172.95627.38 192.55638.05
GSH mM, median (IQR) 3.87 (2.93–5.28) 3.92 (3.02–5.82) 3.87 (2.91–5.21)
GluCys mM, mean 6SD 4.4061.20 4.3761.26 4.4161.17
aCalculated using the modification of diet in renal disease formula.
doi:10.1371/journal.pone.0084918.t001
Figure 2. Distribution of ERT concentrations in the HCS sample after (A) grouping according to the gender and (B) to the presence
or absence of disease and by gender. The lower and upper lines of the box correspond to the 25th and 75th percentiles, respectively. The line in
the middle of the box represents the median. The error bars are situated at ,1.5 times the interquartile range (ie, 75th percentile to 25th percentile)
from the upper and lower lines of the box. %, #: outliers.
doi:10.1371/journal.pone.0084918.g002
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was tested by measuring the tolerance and the variance inflation
factor values for each analysis. A 2-sided P value of 0.05 indicated
statistical significance.
Results
Demographic, clinical, and biochemical characteristics of the
study sample are outlined in Table 1. ERT serum concentration
distribution was skewed, with ,45% of the study population
having concentrations between 0.5 and 1.0 mmol/L (Figure 1).
Median ERT serum concentration was 1.01 IQR 0.78–
1.33 mmol/L. No significant gender-related differences were
observed (females 0.97 IQR 0.75–1.32 mmol/L vs. males 1.04
IQR 0.80–1.36 mmol/L, P = 0.41) (Figure 2A). The majority of
participants (81.8%) had at least one chronic condition, such as
hypertension (59.9%), angina (5.8%), osteoarthritis (28.7%),
rheumatoid arthritis (6.7%), diabetes (13.6%), thyroid problems
(12.3%), depression (24.8%), emphysema (13.9%), and osteopo-
rosis (7.0%). Moreover, a small proportion had suffered a
myocardial infarction (7.5%) or a stroke (3.6%). Only 18.2% of
the participants did not suffer from any apparent disease.
Those with at least one chronic medical condition were
classified as unhealthy (N = 359) while those without were
classified as healthy (N = 80). The presence of a chronic medical
condition was not associated with a significant difference in ERT
serum concentrations [healthy subjects (n = 80) 0.99 IQR 0.84–
1.52 mmol/L vs. unhealthy subjects (n = 359) 1.01 IQR 0.77–
1.33 mmol/L, P = 0.15]. In the subgroups obtained by a further
split according to the gender, ERT serum concentration was
slightly higher in males than females but the difference was not
statistically significant both in healthy (P = 0.99) and unhealthy
(P = 0.41) groups (Figure 2B). In view of the similar ERT serum
concentrations in healthy vs. unhealthy groups and males vs.
females, further analyses were performed by considering the
cohort as a whole. As displayed in Table 2, Spearman rank
correlation tests showed a statistically significant negative corre-
lation between ERT serum concentration and age (rho =20.165;
P = 0.0005), Hcy (rho =20.139 P = 0.0036), Cys (rho =20.111
P = 0.02) and GluCys (rho =20.202 P,0.0001). ERT concentra-
tions were also negative correlated with GSH (rho =20.0927
P = 0.05) and positively correlated with eGFR (rho = 0.149;
P = 0.0018). No statistically significant correlations were observed
with either BMI (rho = 0.0666 P = 0.16), CysGly (rho =20.0724
P = 0.13) or Tau (rho = 0.0101; P = 0.83).
To detect potentially confounding variables, we performed a
partial correlation analysis by using gender and healthy state as
covariates and age, BMI, eGFR, Tau, Hcy, GSH, Cys, CysGly,
and GluCys as covariates or as variables. This analysis confirmed
only the statistically significant negative association of ERT serum
concentration with age (rpartial =20.105; P = 0.03) and with
GluCys (rpartial =20.113; P = 0.02). When redundant, non-
significant variables were removed by using stepwise multiple
regression analysis (Forward+Backward method), independent and
stronger associations with age (rpartial =20.150; P = 0.0022) and
with GluCys (rpartial =20.132; P = 0.0060) were observed
(Table 3). The goodness of the model also improved as the F-
ratio and significance magnitude increased from 3 (P = 0.001) to
12 (P,0.001). By considering only the healthy group (n = 80), the
reference interval calculated by the robust method (CLSI C28-A3)
[24] for smaller sample sizes ranged from 0.36 (90% CI 0.31–0.44)
to 3.08 (90% CI 2.45–3.76) mmol/L.
Discussion
Low-molecular-weight thiols have been extensively investigated
in older adults [25]. By contrast, little is known about ERT serum
concentrations in this group. Studies have focused mainly on its
content in foods, animals and in the whole blood or erythrocytes of
healthy subjects or patients with autoimmune diseases. We
demonstrated that ERT is measurable in serum and, differently
from what is reported in the literature for the plasma ERT levels,
the concentration in serum appears generally lower than that
expected considering from 2 to 9 times the content of red blood
cells [14]. Due to the lack of direct measurements of ERT
concentrations in erythrocytes or whole blood we could not
directly assess ratios between these compartments and serum.
However, serum ERT concentration in the HCS sample was
consistent with plasma ERT levels measured by our group on a
small set of age-matched subjects [16,26], where the whole blood/
plasma ratio was an average 40. However, given the circumstantial
nature of this result, a more depth investigation of the ratio is
currently under investigation in our laboratory.
Despite the analogies suggested by some authors with GSH, e.g.
the antioxidant activity and the similarities between intracellular
and extracellular concentrations, no independent association was
found in this study between ERT and GSH. Similarly, no
independent association was observed with Tau, the other
antioxidant considered in the study.
Although bivariate analysis showed associations between ERT
serum concentration and other aminothiols (Hcy, Cys, and
GluCys), stepwise regression only showed independent negative
associations with GluCys. Age was the only other variable showing
independent negative associations with ERT serum concentra-
tions. Although ERT concentration reduces with age, and indeed
the median age in the unhealthy group was higher vs. healthy
subjects (66.067.7 years vs. 63.566.1 years), ERT concentrations
are unlikely to serve as an index of health status. The ERT
Table 2. Correlation analysis.
ERT P-value
Age rho =20.165 0.0005
CysGly rho =20.072 0.1314
Hcy rho =20.139 0.0036
Cys rho =20.111 0.0207
GSH rho=20.092 0.0539
GluCys rho =20.202 ,0.0001
Tau rho = 0.010 0.8337
eGFR rho = 0.149 0.0018
BMI rho = 0.067 0.1633
Spearman rank correlation between ERT concentrations, demographic factors,
and biochemical variables.
doi:10.1371/journal.pone.0084918.t002
Table 3. Stepwise regression of serum ERT concentrations.
B coefficient (95% CI) rpartial P-value
Log Age 20.6 (20.98 to 20.22) 20.150 0.0022
GluCys 20.02 (20.04 to 20.01) 20.132 0.006
The variables entered in the model were healthy status, gender, age, BMI, eGFR,
CysGly, Hcy, Cys, GSH, GluCys, and Tau.
doi:10.1371/journal.pone.0084918.t003
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concentrations between two groups were, in fact, not significantly
different, and almost all ERT values in unhealthy subjects (,98%)
lie within the reference interval (0.36–3.08 mmol/L). The
decreased levels of ERT with age could reflect either a
modification of dietary habits or alterations in the expression of
the SLC22A4 gene.
The negative association between ERT and GluCys is not easy
to explain, also in view of the lack of a clear relation with GSH.
GluCys, the immediate precursor of GSH, is synthesised by the
enzyme glutamylcysteine synthetase in the c-glutamyl cycle. The
activity of glutamylcysteine synthetase is limited by availability of
Cys and glutamate, and is inhibited by GSH through a feedback
mechanism [27]. Recent studies have showed that GluCys is a
thiol-redox regulator that efficiently detoxifies mitochondrial ROS
by acting as glutathione peroxidase-1 cofactor [28] and inhibits
oxidative stress in human endothelial cells [29]. Moreover, GluCys
modulates the trans-membrane transport of several cationic amino
acids [30]. ERT might act similarly to GSH, i.e. by inhibiting the
glutamylcysteine synthetase activity. This might explain the weak
association between ERT and GSH. However, further experi-
mental support is necessary to corroborate these findings and to
provide mechanistic insights.
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